Prolong Pharmaceuticals, LLC 401(K) Plan — Form 5500 plan (Prolong Pharmaceuticals, LLC)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Prolong Pharmaceuticals, LLC 401(K) Plan is a benefit plan reported by Prolong Pharmaceuticals, LLC under EIN 27-1299468 and plan number 001. The latest loaded filing year is 2023. The filing reports 35 participants and $3,015,640 in end-of-year plan assets, where available in the loaded dataset.
Key reported metrics
- Plan sponsor
- Prolong Pharmaceuticals, LLC
- EIN
- 27-1299468
- Plan number
- 001
- Plan type
- 2
- Location
- South Plainfield, NJ
- Latest filing year
- 2023
- Participants
- 35
- End-of-year plan assets
- $3,015,640
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 35 | I | 20240825114336NAL0004160643001 |
Reported financial statement (2023 · Schedule I)
Net assets
- Total assets (EOY)
- $3,015,640
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $3,015,640
- Net assets (BOY)
- $2,744,358
Income & contributions
- Employer contributions
- $0
- Participant contributions
- $34,141
- Total income / additions
- $484,971
Expenses & distributions
- Benefits paid
- $200,335
- Administrative expenses
- $13,354
- Total expenses
- $213,689
- Net increase / (decrease)
- $271,282
Service provider compensation (Schedule C)
No Schedule C service provider compensation is loaded for this plan yet.